A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed towards science, industry and politics.
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
A recently established technique termed pharming uses genetically modified plants and animals for the production of biopharmaceuticals. The present interdisciplinary study comprises an extended overview of the state of the art of pharming, as well as in depth analyses of the environmental risks and other ethical and legal issues of pharming. Public attitudes to pharming are investigated on the basis of an original survey in 15 countries worldwide. The study concludes with specific recommendations addressed towards science, industry and politics.
Imprint | Springer-Verlag |
Country of origin | Germany |
Series | Ethics of Science and Technology Assessment, 35 |
Release date | October 2008 |
Availability | Expected to ship within 10 - 15 working days |
First published | 2009 |
Authors | Eckard Rehbinder, Margret Engelhard, Kristin Hagen, R.B. Jorgensen, Rafael Pardo Avellaneda, Angelika Schnieke, Felix Thiele |
Dimensions | 235 x 155 x 20mm (L x W x T) |
Format | Hardcover |
Pages | 334 |
Edition | 2009 ed. |
ISBN-13 | 978-3-540-85792-1 |
Barcode | 9783540857921 |
Categories | |
LSN | 3-540-85792-3 |